ArticleArthritis research & therapy2026
Insights into axial spondyloarthritis features and the development of imaging evidence of sacroiliitis during long-term follow-up in routine clinical practice.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyse characteristics and SpA features of newly diagnosed patients with radiographic (r-) versus non-radiographic (nr-)axSpA, and nr-axSpA patients fulfilling the imaging versus clinical arm of the ASAS classification criteria. Furthermore, this study explored whether patients from the clinical arm developed imaging evidence of sacroiliitis during follow-up.
methodsConsecutive newly diagnosed axSpA patients included in the prospective GLAS cohort between 2009 and 2019 were analysed. Demographic data and SpA features were compared between groups using multivariable logistic regression analysis. Patients fulfilling the clinical arm were evaluated for the development of radiographic sacroiliitis during follow-up.
results305 patients with a recent axSpA diagnosis were included. Mean age was 38 ± 12 years, 55% were males, median diagnostic delay was 6 (IQR 2–13) years, and 75% were HLA-B27+. Patients diagnosed with r-axSpA (n = 170; 56%) were more often male and had more often elevated CRP than patients diagnosed with nr-axSpA. Patients with nr-axSpA had more often inflammatory back pain and a positive family history of SpA. Clinical diagnosis was made without imaging evidence of sacroiliitis in 38 (12%) patients. Only 2 (5%) of these patients later developed sacroiliitis on imaging (median follow-up 8 years).
conclusionOverall, diagnosed and classified axSpA patients have similar clinical presentation and disease burden. In approximately 1 in 10 patients, axSpA diagnosis was made without imaging evidence of sacroiliitis, with a negligible number developing sacroiliitis on imaging during long-term follow-up. Imaging may improve diagnostic confidence, which can prevent reconsideration of the diagnosis and reduce inappropriate management decisions and expectations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.